Nigerian Scientist in ABU Develops New Malaria Vaccine
A professor in the Biochemical Parasitology Department of Ahmadu Bello University (ABU), Zaria, Nasiru Shua’Ibu has developed a new malaria vaccine to prevent high rate of death from malaria fever. Speaking with the News men in Zaria, Kaduna State on Tuesday, Mr. Shu’aibu said the new malaria vaccine was different from others currently in use.
Mr. Shu’aibu, who is currently working with the Institute of Tropical Medicine, Japan, said the result of the research on the new vaccine would soon be out for Nigerians to use. “In a simple term that a layman can understand, the content of this malaria vaccine research is difficult, but let me try if I could simplify it, it is called DNA Vaccine. He said that it is a new technology for discovery and delivery of vaccine against any infectious disease that was developed in the early to mid 1990s. “The DNA of the malaria parasite was extracted and the portion of the DNA that is tested to be a good vaccine candidate is subjected to molecular biology methods which are used to produce a lot of the DNA. According to him, the amount of DNA from the malaria parasite was very minute in quantity and to expand the quantity, Polymerase Chain Reaction (PCR) was used. “Then a method of cloning is now used to insert the DNA into a vehicle that will carry the DNA into either animal or human body and then injected into the body of the animal or human and it eventually enters the cells of the animal in the same way a virus enters and infects cells. Mr. Shu’aibu also said that the injected DNA now uses the cells in the body to produce chemicals that will prevent malaria from infecting the body, saying that the vaccine was different from any of the licensed vaccines like polio and other EPI vaccines and that the approach was also different from the other malaria vaccine (RTS,S/AS01) that was likely to be licensed but the goals were the same, to control and eventually eliminate malaria.

No Comments

Leave a Comment